- Home
- TIL vs MAV Comparison
TIL vs MAV Comparison
Compare TIL & MAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIL
- MAV
- Stock Information
- Founded
- TIL 2018
- MAV 2003
- Country
- TIL United States
- MAV United States
- Employees
- TIL N/A
- MAV N/A
- Industry
- TIL Biotechnology: Pharmaceutical Preparations
- MAV Finance Companies
- Sector
- TIL Health Care
- MAV Finance
- Exchange
- TIL Nasdaq
- MAV Nasdaq
- Market Cap
- TIL 171.7M
- MAV 184.1M
- IPO Year
- TIL 2021
- MAV N/A
- Fundamental
- Price
- TIL $14.48
- MAV $8.15
- Analyst Decision
- TIL Buy
- MAV
- Analyst Count
- TIL 5
- MAV 0
- Target Price
- TIL $114.00
- MAV N/A
- AVG Volume (30 Days)
- TIL 178.2K
- MAV 66.2K
- Earning Date
- TIL 05-13-2025
- MAV 01-01-0001
- Dividend Yield
- TIL N/A
- MAV 4.30%
- EPS Growth
- TIL N/A
- MAV N/A
- EPS
- TIL N/A
- MAV N/A
- Revenue
- TIL N/A
- MAV N/A
- Revenue This Year
- TIL N/A
- MAV N/A
- Revenue Next Year
- TIL N/A
- MAV N/A
- P/E Ratio
- TIL N/A
- MAV N/A
- Revenue Growth
- TIL N/A
- MAV N/A
- 52 Week Low
- TIL $9.62
- MAV $6.37
- 52 Week High
- TIL $92.00
- MAV $8.34
- Technical
- Relative Strength Index (RSI)
- TIL 46.45
- MAV 51.81
- Support Level
- TIL $10.80
- MAV $7.82
- Resistance Level
- TIL $13.52
- MAV $8.20
- Average True Range (ATR)
- TIL 2.23
- MAV 0.08
- MACD
- TIL -0.17
- MAV 0.05
- Stochastic Oscillator
- TIL 27.06
- MAV 88.91
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About MAV Pioneer Municipal High Income Advantage Fund Inc.
Pioneer Muni High Income Advantage Tr is a closed-end fund designed to pursue high current income exempt from regular federal income tax and as a secondary objective to seek capital appreciation. It predominantly invests in debt securities and other obligations issued by or on behalf of states, territories, and possessions of the United States and the District of Columbia and their political subdivisions, agencies, and instrumentalities, the interest on which is exempt from regular federal income tax.